Skip to content
BidBenchmark

Contract award

NOVARTIS PHARMACEUTICALS CORPORATION

PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)
PIID
36C26226F0048
Award key
CONT_AWD_36C26226F0048_3600_36F79720D0180_3600
Recipient UEI
NG61ZA8TADW3
Parent award
CONT_IDV_36F79720D0180_3600
Source as of
—
Current award value
$1,646,1243
Obligated to date
$1,646,1242
Potential with options
$5,607,4253
Awarding agency
Department of Veterans AffairsDepartment of Veterans Affairs
Place of performance
Phoenix, Arizona
Set-aside
None
Pricing
Firm Fixed Price
Competition
Full and Open Competition1 offers received
Period of performance
Jan 2, 2026 — Jan 1, 2027Through Jan 1, 2031 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Dec 30, 2025Initial award$1,023,070.80$1,646,124.48
P00001Jan 20, 2026B$0.00$1,646,124.48
P00002Sep 17, 2026C$623,053.68$1,646,124.48

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.gov—Sep 20, 2026usaspending_contract_csv@2026.08.2b106fa2a271f
contractor_idUSAspending.gov—Sep 20, 2026usaspending_contract_csv@2026.08.2b106fa2a271f
current_award_valueUSAspending.gov—Sep 20, 2026usaspending_contract_csv@2026.08.2b106fa2a271f
naics_codeUSAspending.gov—Sep 20, 2026usaspending_contract_csv@2026.08.2b106fa2a271f
potential_award_valueUSAspending.gov—Sep 20, 2026usaspending_contract_csv@2026.08.2b106fa2a271f
psc_codeUSAspending.gov—Sep 20, 2026usaspending_contract_csv@2026.08.2b106fa2a271f
total_obligatedUSAspending.gov—Sep 20, 2026usaspending_contract_csv@2026.08.2b106fa2a271f

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 3 transaction records parsed from USAspending.gov, retrieved Sep 20, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
36C26226F0048 — NOVARTIS PHARMACEUTICALS CORPORATION · BidBenchmark